ProThera Biologics, Inc

Categories

Biotechnology

About

ProThera Biologics is a biotherapeutics company developing plasma, Inter-Alpha Inhibitor Proteins (IAIP) to treat the inflammation associated with severe acute diseases. IAIP are platform proteins and are applicable to many disease areas and can be used as adjunctive treatments to current standards of care.  IAIP modulate inflammation by multiple mechanisms and play a role in tissue repair. IAIP are being developed both as a therapeutic and as a rapid, point of care, biomarker test. Current therapeutic indication areas are severe community acquired pneumonia and ischemic stroke, as well as the orphan indications, neonatal hypoxic ischemic brain injury and necrotizing enterocolitis.

 

Contacts

Primary
Dawn Marshall
Controller and Grants Manager

Yow-Pin Lim
Founder & CEO

Powered By GrowthZone